Learn More
Medchemexpress LLC Vimseltinib (DCC-3014) | 1628606-05-2 | 99.94% | 431.49 | 50 MG

Supplier: Medchemexpress LLC HY13625650MG
Vimseltinib, also known as DCC-3014, is a c-FMS (CSF-1R) and c-Kit dual inhibitor. This compound has demonstrated anti-cancer and anti-proliferative activities with certain oral bioavailability, making it suitable for various research applications.
- c-FMS (CSF-1R) and c-Kit dual inhibitor
- Has anti-cancer activities
- Has anti-proliferative activities
- Possesses oral bioavailability
- IC50s of <0.01 μM for c-FMS/CSF-1R
- IC50s of 0.1-1 μM for c-Kit
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.